Compare DLPN & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLPN | IRIX |
|---|---|---|
| Founded | 1996 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.1M | 18.2M |
| IPO Year | 2008 | 1996 |
| Metric | DLPN | IRIX |
|---|---|---|
| Price | $1.46 | $1.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 21.6K | ★ 133.3K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.87 | 51.85 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $56,699,389.00 | $41,593,000.00 |
| Revenue This Year | $14.73 | $3.07 |
| Revenue Next Year | $7.41 | $6.66 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 9.70 | N/A |
| 52 Week Low | $0.99 | $0.87 |
| 52 Week High | $1.88 | $1.65 |
| Indicator | DLPN | IRIX |
|---|---|---|
| Relative Strength Index (RSI) | 49.65 | 44.49 |
| Support Level | $1.45 | $1.01 |
| Resistance Level | $1.65 | $1.14 |
| Average True Range (ATR) | 0.07 | 0.04 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 52.17 | 30.00 |
Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.